Related Experiment Videos

Point mutations and deletions in the znfn1a1/ikaros gene in chemically induced murine lymphomas

Anneli Karlsson1, Peter Söderkvist, Shi-Mei Zhuang

  • 1Division of Cell Biology, Department of Biomedicine and Surgery, Faculty of Health Sciences, Linköping University, S-581 85 Linköping, Sweden.

Cancer Research
|May 1, 2002
PubMed

Insights

Mutations in the Ikaros gene (Znfn1a1) were found in chemically induced lymphomas, suggesting Ikaros acts as a tumor suppressor. These genetic alterations impact its DNA-binding and functional domains.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Immunology

Background:

  • The Znfn1a1 gene encodes Ikaros, a zinc finger protein essential for T-cell development.
  • Ikaros function relies on DNA binding, transactivation, and dimerization domains.

Purpose of the Study:

  • To investigate mutations and deletions in functional domains of the Znfn1a1 gene in murine lymphomas.
  • To assess the role of Ikaros inactivation in chemically induced lymphomas.

Main Methods:

  • Analysis of exons 3-5 and exon 7 of the Znfn1a1 gene for point mutations and deletions.
  • Southern blot analysis for homozygous deletions.
  • Allelotyping for losses on markers surrounding the Znfn1a1 gene.

Main Results:

  • Point mutations (missense and frameshift) were identified in 11% of lymphomas, with 8 in DNA-binding motifs.
  • Frameshift mutations in exon 7 affected transactivation and dimerization domains.
  • Homozygous deletions in functional domains occurred in 4% of lymphomas; allelic losses near Znfn1a1 were observed in 27%.

Conclusions:

  • Inactivation of Ikaros occurs in a subset of chemically induced lymphomas.
  • Results support the tumor-suppressor activity of Ikaros.
  • Other tumor suppressor genes near Znfn1a1 may also be involved.

Related Concept Videos